US$ 26.78
clean nutrition options for glp-1 diet product developers GLP‑1 Disruption, Nestlé's Strategy Shift and Reformulation Pressure Beyond GLP-1 Agonists: An Adaptive
Description
BMI 27 with obesity-related comorbidities or significant weight loss resistance

Patients will also be charged a monthly provider support fee of $79/month

Canadian Agency for Drugs and Technologies in Health
Other new treatments that have come on-stream or will do so in 2025, particular in the central nervous system/CNS category and neurological conditions are also expected to drive up costs in 2025

These inducers can help individuals transition away from GLP-1 medications while maintaining effective weight and glucose level management

Li L, Li S, Deng K, Liu J, Vandvik PO, Zhao P, et al
